Some Parkinson's patients will be taking Tasmar (tolcapone)

March 1998

    Some Parkinson's patients will be taking Tasmar (tolcapone). It's the first drug in a new class...called COMT inhibitors.

    COMT (catechol-O-methyltransferase) is an enzyme that metabolizes levodopa to an INACTIVE metabolite. Blocking this enzyme increases the half-life of levodopa and prolongs its effect.

    Think of Tasmar as a "levodopa booster."

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote